| RS1057524572 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1057524573 |
SCN2A
|
Health Risk |
Likely pathogenic |
Benign familial neonatal-infantile seizures 1, Developmental and epileptic encephalopathy |
| RS1057524581 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS1057524584 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS1057524588 |
EFTUD2
|
Health Risk |
Pathogenic |
— |
| RS1057524593 |
PORCN
|
Health Risk |
Pathogenic |
— |
| RS1057524595 |
KCNH2
|
Health Risk |
Likely pathogenic |
— |
| RS1057524599 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1057524602 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1057524605 |
SLC52A3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1057524608 |
PHEX
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1057524616 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1057524625 |
TMEM43
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS1057524634 |
EARS2
|
Health Risk |
Likely pathogenic |
— |
| RS1057524637 |
PURA
|
Health Risk |
Pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS1057524638 |
WDR81
|
Health Risk |
Pathogenic |
— |
| RS1057524643 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia |
| RS1057524645 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1057524647 |
VEGFC
|
Health Risk |
Pathogenic |
Squamous cell carcinoma of the head and neck, Squamous cell carcinoma of the head and neck |
| RS1057524648 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1057524653 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1057524663 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS1057524670 |
KCNC1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Progressive myoclonic epilepsy type 7 |
| RS1057524676 |
FGF8
|
Health Risk |
Likely pathogenic |
— |
| RS1057524677 |
CHD8
|
Health Risk |
Pathogenic/Likely pathogenic |
CHD8-related disorder, CHD8-related disorder |
| RS1057524680 |
SMARCAL1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524681 |
SMARCAL1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524688 |
KCNB1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524689 |
KMT2D
|
Health Risk |
Likely pathogenic |
— |
| RS1057524690 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 1 |
| RS1057524693 |
UBE2A
|
Health Risk |
Pathogenic |
— |
| RS1057524695 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1057524696 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS1057524697 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1057524700 |
PPM1D
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1057524702 |
GBA1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524703 |
ACTG1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524707 |
GDF1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524708 |
CSNK2A1
|
Health Risk |
Pathogenic |
— |
| RS1057524714 |
TALDO1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524715 |
IVD
|
Health Risk |
Likely pathogenic |
— |
| RS1057524718 |
TUBB
|
Health Risk |
Likely pathogenic |
— |
| RS1057524722 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1057524724 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1057524727 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Hypophosphatasia |
| RS1057524732 |
FOXP1
|
Health Risk |
Pathogenic |
— |
| RS1057524735 |
FBN1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524736 |
KIF11
|
Health Risk |
Pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS1057524737 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1057524751 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1057524752 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1057524755 |
LOXHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1057524757 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Marfan syndrome |
| RS1057524761 |
SPTBN2
|
Health Risk |
Likely pathogenic |
— |
| RS1057524765 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS1057524775 |
CAMTA1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524777 |
NLRP3
|
Health Risk |
Likely pathogenic |
— |
| RS1057524787 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1057524790 |
HNF4A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1057524791 |
IL12RB1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524792 |
LIAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Lipoic acid synthetase deficiency, Inborn genetic diseases |
| RS1057524795 |
STXBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile epilepsy syndrome, Developmental and epileptic encephalopathy |
| RS1057524798 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1057524799 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth Neuropathy X |
| RS1057524802 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Menke-Hennekam syndrome 1, Inborn genetic diseases |
| RS1057524804 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Timothy syndrome, Long QT syndrome |
| RS1057524809 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS1057524810 |
TGFBR2
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1057524820 |
SCN8A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS1057524821 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1057524822 |
TRMU
|
Health Risk |
Likely pathogenic |
— |
| RS1057524825 |
DMD
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS1057524829 |
FOLR1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524831 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS1057524832 |
MBD5
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS1057524834 |
STXBP1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524835 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS1057524838 |
TTN
|
Health Risk |
Pathogenic |
— |
| RS1057524842 |
AHI1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524843 |
AHI1
|
Health Risk |
Pathogenic |
— |
| RS1057524847 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1057524848 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS1057524850 |
STAG1
|
Health Risk |
Likely pathogenic |
STAG1-related disorder, STAG1-related disorder |
| RS1057524857 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1057524858 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, Central core myopathy |
| RS1057524860 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS1057524862 |
PC
|
Health Risk |
Likely pathogenic |
— |
| RS1057524864 |
DGUOK
|
Health Risk |
Pathogenic |
— |
| RS1057524865 |
NDUFA11
|
Health Risk |
Likely pathogenic |
— |
| RS1057524868 |
GLB1
|
Health Risk |
Likely pathogenic |
— |
| RS1057524869 |
NKX2-1
|
Health Risk |
Likely pathogenic |
Brain-lung-thyroid syndrome, Brain-lung-thyroid syndrome |
| RS1057524873 |
COL1A2
|
Health Risk |
Pathogenic |
COL1A2-related disorder, COL1A2-related disorder |
| RS1057524874 |
PTEN
|
Health Risk |
Pathogenic |
Macrocephaly-autism syndrome, Cowden syndrome 1 |
| RS1057524876 |
NLRP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autoinflammation with arthritis and dyskeratosis, Autoinflammation with arthritis and dyskeratosis |
| RS1057524878 |
SYNJ1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 53 |
| RS1057524879 |
SYNJ1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 53 |
| RS1057524880 |
SYNJ1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 53 |
| RS1057524883 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Cardiovascular phenotype |
| RS1057524885 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Cardiovascular phenotype |
| RS1057524887 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Wolfram syndrome 1 |